drugset / Trial / NCT01438944
Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction
Phase 1
Completed
52 enrolled
The Queen Elizabeth Hospital
Basil Hetzel Institute for Translational Research · collabClinical Practice Unit · collabTherapeutics Research Centre · collabUniversity of Adelaide · collabUniversity of South Australia · collab
NaSingle-groupOpen-labelHealth-services research
Summary
Evaluation to determine if auto-induction can be used as a surrogate measure of nicotine receptor up-regulation through an observational study using nicotine replacement therapy for two weeks and no intervention for two weeks.
Timeline
- Start
- 2011-07
- Primary completion
- 2015-07
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicabate | Unknown | 21 mg | Other |